Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Cash from Operations (2016 - 2025)

Medifast (MED) has disclosed Cash from Operations for 16 consecutive years, with 5278000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 6.69% year-over-year to 5278000.0, compared with a TTM value of 6863000.0 through Dec 2025, down 71.96%, and an annual FY2025 reading of 6863000.0, down 71.96% over the prior year.
  • Cash from Operations was 5278000.0 for Q4 2025 at Medifast, down from 12113000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 65326000.0 in Q1 2021 and bottomed at 7459000.0 in Q4 2021.
  • Average Cash from Operations over 5 years is 23405550.0, with a median of 14434500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations soared 793.65% in 2022, then plummeted 147.02% in 2024.
  • Year by year, Cash from Operations stood at 7459000.0 in 2021, then skyrocketed by 793.65% to 51739000.0 in 2022, then crashed by 79.66% to 10522000.0 in 2023, then plummeted by 147.02% to 4947000.0 in 2024, then dropped by 6.69% to 5278000.0 in 2025.
  • Business Quant data shows Cash from Operations for MED at 5278000.0 in Q4 2025, 12113000.0 in Q3 2025, and 3378000.0 in Q2 2025.